Navigation Links
Early Stage, Step 8: Misclassifying workers brings risk

n. He has a law degree and an MBA from University of Wisconsin-Madison and a bachelor's degree from St. Norbert College.

Bonnie Wendorff also is an attorney with Neider & Boucher, and her areas of expertise include employment law and litigation. She has a law degree from the University of Wisc......

Full article >>>
'"/>

Source:wistechnology.com By Joe Boucher and Bonnie Wendorff 03/07/07


Page: 1 2 3 4 5

Related biology technology :

1. Early Stage: Step 11 - Other forms of finance
2. Early Stage 10: The nuances of federal laws
3. Early Stage, Step 9: Raising capital in the securities landscape
4. Early Stage 7, Part I: Just what is an employee?
5. Early Stage: Step 6 - Taxes, taxes, taxes!
6. Early Stage: Step 5 - Forming the entity
7. Early Stage, Step 4: Cautionary trademark tales
8. Early Stage, Step 3: Naming the entity
9. Early-stage quality brings investment, Meier says
10. Early-stage executives hear from investors
11. Early Stage Step 2: Choosing a domain name

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Early Stage Step Misclassifying workers brings risk

(Date:11/4/2009)...his webinar, which will be presented on November 1...us flow chemistry processing, will deal with the a...arious meso and micro scale flow chemistry equipme... has been recognized with several prestigious priz...trahedron Prize. , Columb...
(Date:11/4/2009).... 4 DIATHERIX Laboratories, Inc. (...d at the Michigan Security Network Homeland Securi... Dennis Grimaud, Chairman and Chief Executive Offi...any,s advanced molecular diagnostic testing on bio...se diagnosis and military efforts. ,, "This co...
(Date:11/4/2009)...Md., Nov. 4 Zyngenia, Inc., a priv...-generation antibody drug development, today annou...unding from New Enterprise Associates (NEA), one o...apital will be used to create novel, multi-specifi... biological targets with a single agent. The compa...
(Date:11/4/2009)...ov. 4 Nektar Therapeutic...sults for the third quarter ended September 30, 20...r 30, 2009 improved to $31.0 million or $0.33 per ...or $0.40 per share in the third quarter of 2008. ...ts operating efficiencies as compared to a year ag...
Breaking Biology Technology:Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3DIATHERIX Laboratories Presents at Homeland Security Conference 2Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10
... A plenary panel discussion o...uot; featuring five of the most outstanding scient... among the highlights of the 2009 Bio-IT World Con...orld Trade Center in Boston. , ...lenary panel discussion on the exciting field of &...
...WOOD CITY, Calif., March 31 Codexis, Inc. today a...new position of Vice President, Systems Biology fo...cellular engineering, molecular biology, and compu...n, Ph.D., Vice President, Bioindustrials Research ...cted researcher in the directed evolution of genes...
... -- New Claims Cover Phospholipid-Targeting Compou...Calif., March 31 Peregrine Pharmaceuticals, Inc. ... U.S. patent that further strengthens the company,... phospholipid-targeting agents for the treatment o...s composition of matter claims that cover multiple...
Other Biology Technology:Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics" 2Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics" 3Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics" 4Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics" 5Codexis Names Lori Giver VP Systems Biology 2Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio 2Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio 3Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio 4
(Date:11/4/2009)... GenVault Corporation, the leader i...omic discovery, medicine and identification, today...esident and CEO, will be presenting at the BIOCOM ...nd 27th in La Jolla, CA. ,, During the presenta...ompany together with recent customer, technical an...
(Date:11/4/2009)... at the University of North Carolina at Chapel Hil...nia, San Francisco have developed and experimental...es for existing drugs. , The researchers develop...r the structures of all known drugs are to the nat...nds -- of disease targets within the cell. In a st...
(Date:11/3/2009)... -- The world,s greatest wines are the result of ...ut, and something called the "terroir" -- a term o...te. , Experts will discuss terroir with an emp... Nov. 4 in Pittsburgh. "Terroir: Winegrapes and t...the 2009 Annual Meetings of the American Society o...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Study points to new uses, unexpected side effects of already existing drugs 2Great wines come from great soils 2China Kangtai Cactus Biotech Q2 Revenue Up 30 25 to Record 246 5M 3B Net Income Up 37 25 to 241 4M EPS 240 07 54468 1China Kangtai Cactus Biotech Q2 Revenue Up 30 25 to Record 246 5M 3B Net Income Up 37 25 to 241 4M EPS 240 07 54468 2China Kangtai Cactus Biotech Q2 Revenue Up 30 25 to Record 246 5M 3B Net Income Up 37 25 to 241 4M EPS 240 07 54468 3China Kangtai Cactus Biotech Q2 Revenue Up 30 25 to Record 246 5M 3B Net Income Up 37 25 to 241 4M EPS 240 07 54468 4Hisamitsu Pharmaceutical Announces Expiration of HSR Waiting Period for Its Proposed Acquisition of Noven Pharmaceuticals 54463 1Hisamitsu Pharmaceutical Announces Expiration of HSR Waiting Period for Its Proposed Acquisition of Noven Pharmaceuticals 54463 2First compound that specifically kills cancer stem cells found 54460 1First compound that specifically kills cancer stem cells found 54460 2
...he University of California, Santa Cruz, have dete...nzyme, or "ribozyme," that carries out a fundament...eir results provide insight into what may have bee...lions of years ago on the evolutionary path toward...wn today, the synthesis of DNA and RNA molecules i...
...ack baby" hysteria of the 1980s was greatly exagge...le but disabling cognitive impairments -- attentio...oblems. , A recent study by investigators at the ...velopment may help explain the long-term behaviora...al exposure to cocaine. In a recent issue of the J...
...that a better understanding of how proteins bond c... disorders and other life-threatening conditions. ...ers, new theory has been proven to accurately pred...y is outlined in the February issue of the scienti...ltiple targets or can be targeted by multiple mole...
Other Biology News:RNA enzyme structure offers a glimpse into the origins of life 2Prenatal cocaine's lasting cellular effects 2Prenatal cocaine's lasting cellular effects 3FSU researchers determine a critical factor in workings of proteins 2
Porcine IL-1 beta (IL-1F2) ELISpot Kit from R&D Systems
GIBCO Versene 1:5;000 (1X); liquid from Invitrogen
Human Angiogenesis Array 1 Kit, Quantibody from Raybiotech, Inc.
BD IMagnet 1 each from BD Biosciences Pharmingen
Biology Products: